Ralf Kuriyel
Chief Tech/Sci/R&D Officer bij REPLIGEN CORPORATION
Vermogen: 5 M $ op 29-02-2024
Profiel
Momenteel is Ralf Kuriyel Senior Vice President-Research & Development bij Repligen Corp. In het verleden was hij Vice President-Research & Development voor Pall Life Sciences en Vice President-Field Applications R&D bij Pall Corp. De heer Kuriyel behaalde een bachelor en een doctoraal aan het Rensselaer Polytechnic Institute.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
REPLIGEN CORPORATION
0.04% | 11-03-2024 | 24 260 ( 0.04% ) | 5 M $ | 29-02-2024 |
Actieve functies van Ralf Kuriyel
Bedrijven | Functie | Begin |
---|---|---|
REPLIGEN CORPORATION | Chief Tech/Sci/R&D Officer | 18-10-2016 |
Eerdere bekende functies van Ralf Kuriyel
Bedrijven | Functie | Einde |
---|---|---|
PALL CORPORATION | Corporate Officer/Principal | 01-10-2016 |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Chief Tech/Sci/R&D Officer | 01-10-2016 |
Opleiding van Ralf Kuriyel
Tufts University | Doctorate Degree |
Rensselaer Polytechnic Institute | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
REPLIGEN CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Pall Corp.
Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Health Technology |